FibroBiologics closes $0.5M private placement with CSO; shareholders approve warrant issuance

FibroBiologics, Inc.

CSO Hamid Khoja purchased 298,508 shares plus warrants at $1.675 combined price ($1.55 stock + $0.125 warrant) on Sept 15, 2026.
Gross proceeds ~$0.5M; net proceeds to be used for general corporate purposes and working capital.
Warrants exercisable at $1.55, immediately exercisable, expire in 5 years from issuance.
Shareholders approved issuance of up to 8,448,980 shares (8,163,266 + 285,714) upon warrant exercise; votes: 3,153,098 for, 258,217 against.
Special meeting held Sept 17, 2026; 3,431,761 shares represented out of 8,283,193 entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.